BWAY Brainsway Ltd.
$11.23▲ +0.18%
Healthcare
Other
Volume 1.5K
Avg Volume (10D) 86.3K
Key Metrics & Fundamentals
Market Cap
$452.04M
P/E Ratio
48.8
Div Yield
0.00%
52W Range
7.14 - 17.40
% vs 50 MA
-15.30%
% vs 200 MA
-19.51%
RSI-14
34.2
MACD Histogram
+0.0200
Beta (1Y vs SPY)
2.06
Free Cash Flow
$5.42M
Gross Rev
$17.11M
Gross Profit
$12.77M
EBITDA
$4.24M
COGS
$4.34M
Operating Exp
$10.38M
Operating Income
$2.39M
EBIT
$2.39M
Pretax Income
$2.92M
Net Income
$2.71M
EPS (Diluted)
0.07
Price & Volume History
Loading chart…
Recent News
Brainsway Increases Insurance Companies Covering its OCD Treatment
MT Newswires · Oct 26, 2026 8:16 AM ET

BrainsWay Expands U.S. Insurance Coverage for Deep TMS™ Treatment of OCD to Over 118 Million Lives
GlobeNewswire · Oct 26, 2026 7:30 AM ET

BrainsWay Announces Strategic Collaboration with Inland Psychiatry Medical Group
GlobeNewswire · Oct 19, 2026 7:30 AM ET

BrainsWay Reports Rise in Favorable Accelerated Deep TMS™ Coverage to Over 70 Million Covered Lives
GlobeNewswire · Oct 13, 2026 7:30 AM ET

BrainsWay’s (BWAY) Growth Streak Just Got Harder To Ignore
Insider Monkey · Sep 10, 2026 10:56 PM ET

Are Options Traders Betting on a Big Move in Brainsway Stock?
Zacks · Sep 9, 2026 1:58 PM ET

BrainsWay Reports Promising Pilot Study Results in Patients with Depression and Comorbid Early-Stage Alzheimer’s Disease Treated with Deep TMS™
GlobeNewswire · Sep 8, 2026 7:30 AM ET

Wall Street Analysts See a 30.07% Upside in Brainsway (BWAY): Can the Stock Really Move This High?
Zacks · Aug 27, 2026 9:55 AM ET

BrainsWay Deep TMS™ Study Shows 70% Reduction in Patients Experiencing Suicidal Ideation
GlobeNewswire · Aug 27, 2026 7:30 AM ET

Brainsway (BWAY) Upgraded to Buy: Here's Why
Zacks · Aug 17, 2026 12:00 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See BWAY's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.